Russia applies for WHO emergency use tag for its COVID-19 vaccine
Russia was the first country to grant regulatory approval for a novel coronavirus vaccine, and did so before large-scale trials…
Author
Japan’s cabinet approves plan for free COVID-19 vaccines
Japan has struck deals for hundreds of millions of doses from companies including AstraZeneca and Pfizer.
COVID-19 heart changes raise death risk; virus may be lead killer of young adults during surges
The increased risk for death was statistically significant only when changes in the heart’s size, shape, structure, and function…
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT
AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a…
South Korea pharma Celltrion’s COVID test gets US emergency use authorisation
South Korea’s Celltrion said on Monday it has received emergency use authorisation (EUA) from the US Food & Drug…
Vaccine verdict due by early December: Anthony Fauci
More widespread vaccination would not be likely until later in 2021
Mexico may not follow FDA and approve remdesivir for COVID-19
WHO Solidarity drug trial last week concluded remdesivir has little or no impact on a patient’s chances of surviving COVID-19
Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau
It has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine
Bharat Biotech in talks with many countries for clinical trials, manufacture of COVAXIN
The countries are located in South America, Asia and Central Asia, and Eastern Europe
UK to collaborate with Oxford Immunotec to evaluate COVID-19 vaccine T cell responses
T cell immunity is thought to be essential to protect against infection from the SARS-COV-2 coronavirus and could provide…